The 2026 Talc Verdict Scoreboard: 68,435 Claims, Tried One by One

For years, Johnson & Johnson tried to end its talc problem in a single move. Three times it steered its liability into bankruptcy, betting that one court could settle tens of thousands of cancer claims at once. Three times that plan failed. So the claims now move the slow way, through juries, one trial at a time, and 2026 is the year the running total starts to add up.

This is the scoreboard: who is suing, why the cases are being tried individually, and what the year’s mesothelioma verdicts have cost so far. Every figure below traces to a court record or the reporting that named the court.

The Numbers So Far

The headline number is the caseload. As of July 1, 2026, the federal talc litigation held 68,435 pending actions, according to the Judicial Panel on Multidistrict Litigation’s official count. That docket, formally In re Johnson & Johnson Talcum Powder Products, sits in the District of New Jersey before Judge Michael A. Shipp, and it is the largest active multidistrict litigation in the federal system.

Why the Cases Go to Trial at All

The reason the verdicts arrive one at a time is that the shortcut closed. Johnson & Johnson twice placed a subsidiary into Chapter 11 to corral its talc liability, and twice courts rejected the maneuver.

The third attempt, through an entity called Red River Talc, ended on March 31, 2025, when a federal bankruptcy judge in Texas denied the company’s proposed plan. The company confirmed the dismissal in a securities filing and said it would defend the remaining claims in court rather than seek another bankruptcy resolution.

That decision is what turned a single settlement question into thousands of separate trials. Each case now rises or falls on its own record, its own jury, and its own courtroom, which is why a scoreboard, rather than one number, is the honest way to track the cost.

The 2026 Mesothelioma Verdicts

Two mesothelioma verdicts anchor the year so far, and both name the court that entered them.

In Minnesota, a Ramsey County jury awarded $65.5 million in December 2025 to a woman who developed pleural mesothelioma, a cancer of the lung lining tied to asbestos exposure, after childhood use of the company’s talc powder. Johnson & Johnson challenged the award after trial, and in June 2026 the court upheld it, finding the verdict supported by the evidence. The company has said it plans to appeal.

In California, a Los Angeles Superior Court jury awarded $32 million in compensatory damages in June 2026 in another talc mesothelioma case. Before the case reached the jury, the trial judge barred a claim for punitive damages, so the $32 million figure covers compensatory losses only. Johnson & Johnson maintains that its talc is asbestos free and does not cause cancer.

One figure did not make this scoreboard. A widely repeated claim of a roughly $50 million talc verdict in March 2026 traces only to lawsuit-marketing pages, with no court, judge, or case on record, so it is left out until a primary source names one.

The Other Front: the Ovarian Docket

The mesothelioma verdicts are one track. The far larger group of claims in the federal MDL involves ovarian cancer, and there the fight in mid-2026 is over expert testimony rather than dollars.

In June 2026, after the plaintiffs’ side withdrew two of its causation experts, Johnson & Johnson asked the court to dismiss the ovarian-cancer claims in the MDL, arguing they could no longer be proved. That motion, pending before Judge Shipp, could reshape the 68,435-case docket without a single additional jury, which is why the pending count and the verdict count tell only part of the story on their own.

What It Means for Families

For families weighing their options, the scoreboard carries two plain lessons. The first is that talc cancer cases are being decided individually now, so timelines run case by case rather than through one collective settlement. The second is that a headline verdict is a starting point, not a final figure: awards can be reduced after trial, as the barred punitive claim in the Los Angeles case shows, and the company has signaled it will appeal.

The court records, dockets, and verdicts are public. That lets a family and its counsel weigh the specific exposure history and jurisdiction behind a case, rather than a single number from a news alert.